Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
FDMT compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
FDMT
4D Molecular Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
FDMT
4D Molecular Therapeutics, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
FDMT
4D Molecular Therapeutics, Inc.
Change
11.47
▼
−6.60%
Mkt cap
$886.4M
Revenue
$4M
Q2 FY26
Revenue
—
AMGN
Amgen Inc
Change
467.38
▼
−2.32%
Regular session
Nov 5 '26
Mkt cap
$258.8B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
vs
Compare
Regular session
Nov 5 '26
FDMT
4D Molecular Therapeutics, Inc.
vs
AMGN
Amgen Inc
11.47
▼
−6.60%
Price
467.38
▼
−2.32%
$886.4M
Mkt cap
$258.8B
Q2 FY26
$4M
Revenue
$10.4B
Q3 FY26
—
Revenue
$36.8B
FY25
Change
Change
FDMT
11.47
▼
−6.60%
vs
AMGN
467.38
▼
−2.32%
Regular session
Nov 5 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
FDMT: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
FDMT, solid
AMGN, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only FDMT
6
QURE
uniQure
customer
—
Cystic Fibrosis Foundation
unlisted
supplier
—
U.C. Berkeley
unlisted
supplier
—
University of Pennsylvania
unlisted
supplier
2 more · FDMT chain
›
Shared
0
No shared counterparties.
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
8 more · AMGN chain
›